EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model

Understanding the molecular basis of drug resistance and utilising this information to overcome chemoresistance remains a key challenge in oncology. Here we report that survivin, a key protein implicated in drug resistance, is overexpressed in cancer stem cell pool of doxorubicin-resistant breast ca...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Theranostics
Autors principals: Wang, Tao, Gantier, Michael P., Xiang, Dongxi, Bean, Andrew G, Bruce, Matthew, Zhou, Shu-Feng, Khasraw, Mustafa, Ward, Alister, Wang, Li, Wei, Ming Q., AlShamaileh, Hadi, Chen, Lijue, She, Xiaodong, Lin, Jia, Kong, Lingxue, Shigdar, Sarah, Duan, Wei
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2015
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4672025/
https://ncbi.nlm.nih.gov/pubmed/26681989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.11692
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars